Iveric - Decorris List

Japan’s Astellas to buy Iveric Bio for $5.9 billion in US biotech deal

Business (category), Financial Times (category)
May 1, 2023May 4, 2023
by Decorris List

Astellas Pharma has agreed to buy U.S. biotech group Iveric Bio for approximately $5.9 billion, marking the Japanese drugmaker’s largest-ever… Read More »Japan’s Astellas to buy Iveric Bio for $5.9 billion in US biotech deal